HOME › DRUGS › DENOSUMAB-BNHT
ACTIVE SUBSTANCE / INN

DENOSUMAB-BNHT

Brand name(s): BOMYNTRA, CONEXXENCE
FDA LISTED
PRESCRIPTION
BLA761398
ACTIVE SUBSTANCE
Denosumab-Bnht
REGULATORS
FDA
SPONSORS / MAH
FRESENIUS KABI USA LLC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
CONEXXENCEBLA761398FRESENIUS KABI USA LLCPrescription
BOMYNTRABLA761398FRESENIUS KABI USA LLCPrescription

FULL INTELLIGENCE ON DENOSUMAB-BNHT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →